Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | DUT | P33316 | 12/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | CRBN | Q96SW2 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL338055 | 0.79 | ALDH1A1 (0.56) | ALDH1A1LMNAPKMDUTL3MBTL1 | |
| SCHEMBL21803323 | 0.78 | PKM (0.47) | ALDH1A1LMNAPKMDUTL3MBTL1 | |
| SCHEMBL12384319 | 0.78 | PKM (0.51) | ALDH1A1LMNAPKMDUTL3MBTL1 | |
| SCHEMBL2983407 | 0.76 | ALDH1A1 (0.57) | ALDH1A1LMNAPKMDUTL3MBTL1 | |
| SCHEMBL10924758 | 0.74 | PKM (0.55) | ALDH1A1LMNAPKMDUTL3MBTL1 | |
| SCHEMBL4348697 | 0.74 | L3MBTL1 (0.59) | ALDH1A1LMNAPKMDUTL3MBTL1 | |
| SCHEMBL4347791 | 0.73 | ALDH1A1 (0.50) | ALDH1A1LMNAPKMDUTL3MBTL1 | |
| SCHEMBL3079985 | 0.73 | DUT (0.56) | ALDH1A1LMNADUTL3MBTL1CRBN | |
| SCHEMBL6102943 | 0.72 | CRBN (0.56) | ALDH1A1LMNAPKMDUTL3MBTL1 | |
| SCHEMBL912640 | 0.72 | DUT (0.64) | ALDH1A1LMNAPKMDUTL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070249548-A1 | Nucleoside Analog or Salts of the Same | GIFU UNIVERSITY (JP) | 2007-10-25 | — | — | US | disclosed |
| EP-1798225-A1 | NUCLEOSIDE ANALOGUES OR SALTS THEREOF | Gifu University (JP) | 2007-06-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070249548-A1 | Nucleoside Analog or Salts of the Same | NSUN2, RNMT, RNGTT | ALDH1A1 1694/4885LMNA 134/4885PKM 793/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.